Share Your Research, Maximize Your Social Impacts
Vitamin K: A potential Liver Cancer treatment way
Journal: Archives of Hepatitis Research (Vol.3, No. 1)Publication Date: 2017-09-26
Authors : Sofi a Dahlberg; Ulf Schött;
Page : 049-052
Keywords : Vitamin K; Menaquinone; Hepatocellular cancer; Hepatitis; Cirrhosis; PIVKA-II;
Source : Download
Find it from : Google Scholar
Abstract
A review on different vitamin K1-3 effects on hepatocellular cancer and their tumour cell biology mechanism indicate possible synergistic treatment strategies. Monitoring of dysfunctional carboxylation of the vitamin K dependent coagulation factor II, with the commercial ELISA test PIVKA-II has been used as a hepatocellular cancer marker. Its relevance is also reviewed. Currently the PIVKA-II test has been withdrawn due to marketing reasons by Stago.
Other Latest Articles
- Active Navigation in a Hepatitis B Program: Screening, Vaccination and Patient Assistance for Asian Americans in Michigan
- The correlation between serum cytokine levels and liver cirrhosis in chronic hepatitis B patients: A meta-analysis
- Physico-Chemical Factors of Lubilanji River (Oriental Kasaï Province, Democratic Republic of the Congo)
- Present Status and Future Perspectives on Dioxins/Furans and Polychlorinated Biphenyls Policies in Malaysia
- Evaluation of Physico-Chemical Parameters and Minerals Status of Different Water Sources at High Altitude
Last modified: 2019-01-17 20:22:09